INTERNATIONAL PATENT: TYRA BIOSCIENCES, INC. FILES APPLICATION FOR "COMBINATION TREATMENT COMPRISING A FGFR3 INHIBITOR AND A PD-1/PD-L1 INHIBITOR FOR USE IN THE TREATMENT OF CANCER"

GENEVA, Jan. 27 -- TYRA BIOSCIENCES, INC. (2656 State StreetCarlsbad, California 92008) filed a patent application (PCT/US2025/038267) for "COMBINATION TREATMENT COMPRISING A FGFR3 INHIBITOR AND A PD-1/PD-L1 INHIBITOR FOR USE IN THE TREATMENT OF CANCER" on Jul 18, 2025. With publication no. WO/2026/020109, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BENSEN, Daniel C. (c/o Tyra Biosciences2656 State StreetCarlsbad, California 92008), HUDKINS, Robert L. (c/o Tyra Biosciences2656 State StreetCarlsbad, California 92008), ...